Skip to content

Clinical study to evaluate the safety and efficacy of Lunagel 2.5 dermal filler

Clinical study to evaluate the safety and efficacy of Lunagel 2.5 dermal filler (Nikan Teb Kimia CO) for correction of moderate to severe nasolabial fold

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190210042676N33
Enrollment
30
Registered
2024-04-12
Start date
2024-05-21
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasolabial folds. Changes in skin texture

Interventions

Intervention group: One injection with 1-2 cc Lunagel 2.5 dermal filler made by Nikan Teb Kimia CO injectable gel in each nasolabial fold. Lunagel 2.5 is a syringe containing 25 mg of hyaluronic acid

Sponsors

Nikan Teb Kimia CO
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18 -65 years old men and women Moderate to severe nasolabial folds based on Allergan criteria. The opportunity to accompany the visit programs and study process Signing the informed consent form and agree to a 6-month follow-up.

Exclusion criteria

Exclusion criteria: Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment. Planning to undergo any of these procedures at any time during the study.

Design outcomes

Primary

MeasureTime frame
Severity of nasolabial folds. Timepoint: Before intervention and 2 weeks later. Method of measurement: 5 scale Allergan photo numeric grading.

Secondary

MeasureTime frame
Depth, area and volume of nasolabial fold. Timepoint: Before intervention, 2 weeks, 3 and 6 months after intervention. Method of measurement: Visioface camera.;Thickness and density of dermis. Timepoint: Before intervention, 2 weeks and 6 months after intervention. Method of measurement: Skin ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026